Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (631-640 of 831) with videos related to

Pageof 84
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of CancerRobbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, et al.
The Lancet. Oncology|June 9, 2017
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with gliomaAndrea Pace, Linda Dirven, Johan A F Koekkoek, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Acta Neuropathologica|November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaDavid E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibodyLisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Journal of Neuro-Oncology|December 22, 2025
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastasesJacopo Bellomo, Meltem Gönel, Jonathan Sutter, et al.
The Lancet. Oncology|July 8, 2015
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-OncologyKhê Hoang-Xuan, Eric Bessell, Jacoline Bromberg, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology|May 13, 2020
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trialMarianne Schell, Irada Pflüger, Gianluca Brugnara, et al.
Journal of Neuropathology and Experimental Neurology|September 18, 2013
Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylationBenjamin Goeppert, Christopher R Schmidt, Lea Geiselhart, et al.
Pageof 84

Showing results (631-640 of 831) with videos related to

Sort By:
Pageof 84
European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of CancerRobbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, et al.
The Lancet. Oncology|June 9, 2017
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with gliomaAndrea Pace, Linda Dirven, Johan A F Koekkoek, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Acta Neuropathologica|November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaDavid E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibodyLisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Journal of Neuro-Oncology|December 22, 2025
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastasesJacopo Bellomo, Meltem Gönel, Jonathan Sutter, et al.
The Lancet. Oncology|July 8, 2015
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-OncologyKhê Hoang-Xuan, Eric Bessell, Jacoline Bromberg, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology|May 13, 2020
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trialMarianne Schell, Irada Pflüger, Gianluca Brugnara, et al.
Journal of Neuropathology and Experimental Neurology|September 18, 2013
Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylationBenjamin Goeppert, Christopher R Schmidt, Lea Geiselhart, et al.
Pageof 84